Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Bladder Cancer |
Free Subscription
1 Acta Med Okayama |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Bladder Cancer is free of charge.
Prostate Biopsy May Not Be Indicated Early after Bacillus Calmette Guerin
Treatment.
Acta Med Okayama. 2024;78:9-13.
PubMed
Abstract available
Comparing Clinical Efficacy of Different Bacillus Calmette-Guerin Strains in
Patients With T1 High Grade Bladder Cancer.
Anticancer Res. 2024;44:1299-1307.
PubMed
Abstract available
Excavatolide C/cisplatin combination induces antiproliferation and drives
apoptosis and DNA damage in bladder cancer cells.
Arch Toxicol. 2024 Feb 29. doi: 10.1007/s00204-024-03699.
PubMed
Abstract available
Immunohistochemical Expression of Claudin-1 and Claudin-4 in Urothelial Carcinoma
of the Urinary Bladder.
Asian Pac J Cancer Prev. 2024;25:637-646.
PubMed
Abstract available
Comprehensive analysis of mitochondria-related genes indicates that PPP2R2B is a
novel biomarker and promotes the progression of bladder cancer via Wnt signaling
pathway.
Biol Direct. 2024;19:17.
PubMed
Abstract available
Potential molecular biomarkers for the diagnosis and prognosis of bladder cancer.
Biomed Pharmacother. 2024;173:116312.
PubMed
Abstract available
JAM3 is a potential risk biomarker for predicting prognosis and immune cell
infiltration by regulating epithelial-mesenchymal transition in bladder cancer.
Biomol Biomed. 2024 Feb 23. doi: 10.17305/bb.2024.9979.
PubMed
Abstract available
A novel grading approach predicts worse outcomes in stage pT1 non-muscle-invasive
bladder cancer.
BJU Int. 2024 Feb 26. doi: 10.1111/bju.16298.
PubMed
Abstract available
Lessons from a population-based bladder cancer registry: exploring why survival
is not improving.
BJU Int. 2024 Feb 26. doi: 10.1111/bju.16286.
PubMed
Abstract available
The impact of squamous cell transformation on the prognosis of patients treated
with radical nephroureterectomy.
BMC Cancer. 2024;24:247.
PubMed
Abstract available
Vagococcus fluvialis isolation from the urine of a bladder cancer patient: a case
report.
BMC Infect Dis. 2024;24:261.
PubMed
Abstract available
Low-dose Paclitaxel with Pembrolizumab Enhances Clinical and Immunologic
Responses in Platinum-refractory Urothelial Carcinoma.
Cancer Res Commun. 2024;4:530-539.
PubMed
Abstract available
Development and experimental validation of an M2 macrophage and
platelet-associated gene signature to predict prognosis and immunotherapy
sensitivity in bladder cancer.
Cancer Sci. 2024 Feb 29. doi: 10.1111/cas.16113.
PubMed
Abstract available
Integration of CD4(+) T cells and molecular subtype predicts benefit from PD-L1
blockade in muscle-invasive bladder cancer.
Cancer Sci. 2024 Feb 25. doi: 10.1111/cas.16119.
PubMed
Abstract available
New Perspectives on the Role of Liquid Biopsy in Bladder Cancer: Applicability to
Precision Medicine.
Cancers (Basel). 2024;16:803.
PubMed
Abstract available
Urine-Based Biomarker Test Uromonitor((R)) in the Detection and Disease Monitoring
of Non-Muscle-Invasive Bladder Cancer-A Systematic Review and Meta-Analysis of
Diagnostic Test Performance.
Cancers (Basel). 2024;16:753.
PubMed
Abstract available
N(6)-methyladenosine-modified circ_104797 sustains cisplatin resistance in
bladder cancer through acting as RNA sponges.
Cell Mol Biol Lett. 2024;29:28.
PubMed
Abstract available
Pan-cancer analysis reveals potential immunological and prognostic roles of COA6
in human cancers and preliminary exploration of COA6 in bladder cancer.
Cell Signal. 2024;117:111111.
PubMed
Abstract available
Immunogenicity of avelumab in patients with metastatic Merkel cell carcinoma or
advanced urothelial carcinoma.
Clin Transl Sci. 2024;17:e13730.
PubMed
Abstract available
Parkin inhibits proliferation and migration of bladder cancer via ubiquitinating
Catalase.
Commun Biol. 2024;7:245.
PubMed
Abstract available
Ogilvie's Syndrome in a Male With Bladder Cancer.
Cureus. 2024;16:e55097.
PubMed
Abstract available
Prognostic Impact of Histologic Subtype and Divergent Differentiation in Patients
with Metastatic Urothelial Carcinoma Treated with Enfortumab Vedotin: A
Multicenter Retrospective Study.
Curr Oncol. 2024;31:862-871.
PubMed
Abstract available
A Real-World Retrospective Analysis of the Management of Advanced Urothelial
Carcinoma in Canada.
Curr Oncol. 2024;31:704-722.
PubMed
Abstract available
Real-World Insights into Efficacy and Safety of Enfortumab Vedotin in Japanese
Patients with Metastatic Urothelial Carcinoma: Findings, Considerations, and
Future Directions.
Curr Oncol. 2024;31:759-768.
PubMed
Abstract available
Definitions, outcomes and perspectives for oligometastatic bladder cancer:
towards a standardized terminology.
Curr Opin Urol. 2024 Mar 1. doi: 10.1097/MOU.0000000000001170.
PubMed
Abstract available
Progress of Multiparameter Magnetic Resonance Imaging in Bladder Cancer: A
Comprehensive Literature Review.
Diagnostics (Basel). 2024;14:442.
PubMed
Abstract available
International Society of Urological Pathology Consensus Conference on Current
Issues in Bladder Cancer: Main Conclusions and Recommendations.
Eur Urol. 2024 Feb 26:S0302-2838(24)00080-0. doi: 10.1016/j.eururo.2024.
PubMed
Abstract available
PPP3CB Inhibits Cell Proliferation and the Warburg Effect in Bladder Cancer by
Blocking PDHK1.
Front Biosci (Landmark Ed). 2024;29:48.
PubMed
Abstract available
Exploration of potential biomarkers for early bladder cancer based on urine
proteomics.
Front Oncol. 2024;14:1309842.
PubMed
Abstract available
The JAVELIN Bladder Medley trial: avelumab-based combinations as first-line
maintenance in advanced urothelial carcinoma.
Future Oncol. 2024;20:179-190.
PubMed
Abstract available
Immune regulation and the tumor microenvironment in anti-PD-1/PDL-1 and
anti-CTLA-4 therapies for cancer immune evasion: A bibliometric analysis.
Hum Vaccin Immunother. 2024;20:2318815.
PubMed
Abstract available
Efficacy of Platinum-based Chemotherapy in Patients With Metastatic Urothelial
Carcinoma With Variant Histology.
In Vivo. 2024;38:873-880.
PubMed
Abstract available
Applicability and feasibility of robot-assisted cystectomy and intracorporeal
urinary diversion in a patient with right renal pelvic ectopia.
Int Braz J Urol. 2024;50:227-228.
PubMed
Abstract available
Interleukin-1beta/Interleukin (IL)-1-Receptor-Antagonist (IL1-RA) Axis in Invasive
Bladder Cancer-An Exploratory Analysis of Clinical and Tumor Biological
Significance.
Int J Mol Sci. 2024;25:2447.
PubMed
Abstract available
The Role of miRNAs to Detect Progression, Stratify, and Predict Relevant Clinical
Outcomes in Bladder Cancer.
Int J Mol Sci. 2024;25:2178.
PubMed
Abstract available
Comparative analysis of wound healing techniques in postoperative bladder cancer
patients.
Int Wound J. 2024;21:e14820.
PubMed
Abstract available
Hydrogel: a new material for intravesical drug delivery after bladder cancer
surgery.
J Mater Chem B. 2024 Mar 1. doi: 10.1039/d3tb02837.
PubMed
Abstract available
Outcomes of a Dietary Intervention to Reduce Bladder Cancer Recurrence and
Progression in Survivors of Non-Muscle-Invasive Bladder Cancer.
J Natl Compr Canc Netw. 2024 Feb 26:1-9. doi: 10.6004/jnccn.2023.7086.
PubMed
Abstract available
Systematic review comparing uretero-enteric stricture rates between open
cystectomy with ileal conduit, robotic cystectomy with extra-corporeal ileal
conduit and robotic cystectomy with intra corporeal ileal conduit formation.
J Robot Surg. 2024;18:100.
PubMed
Abstract available
Complications Subsequent to Urinary Tract Stent Placement: An Overview Focusing
on the Imaging of Cancer Patients.
Medicina (Kaunas). 2024;60:338.
PubMed
Abstract available
[Retracted] Human HLA?F adjacent transcript 10 promotes the formation of cancer
initiating cells and cisplatin resistance in bladder cancer.
Mol Med Rep. 2024;29:63.
PubMed
Abstract available
Inducing mitochondriopathy-like damages by transformable nucleopeptide
nanoparticles for targeted therapy of bladder cancer.
Natl Sci Rev. 2024;11:nwae028.
PubMed
Abstract available
LncRNA HCP5 Promotes Cell Invasion and Migration by Sponging miR-29b-3p in Human
Bladder Cancer [Retraction].
Onco Targets Ther. 2024;17:159-160.
PubMed
Abstract available
Unraveling the Dietary Puzzle: Exploring the Influence of Diet, Nutraceuticals,
and Supplements on Bladder Cancer Risk, Outcomes, and Immunotherapy Efficacy:
Insights from the BLOSSOM Study and Beyond.
Oncol Ther. 2024 Feb 28. doi: 10.1007/s40487-024-00266.
PubMed
Abstract available
Sacituzumab govitecan plus platinum-based chemotherapy mediates significant
antitumor effects in triple-negative breast, urinary bladder, and small-cell lung
carcinomas.
Oncotarget. 2024;15:144-158.
PubMed
Abstract available
[Histomolecular classification of urothelial carcinoma of the urinary bladder :
From histological phenotype to genotype and back].
Pathologie (Heidelb). 2024;45:106-114.
PubMed
Abstract available
PET/Computed Tomography Transformation of Oncology: Kidney and Urinary Tract
Cancers.
PET Clin. 2024;19:197-206.
PubMed
Abstract available
DaBlaCa-17: nationwide observational study in Denmark on survival before and
after implementation of neoadjuvant chemotherapy prior to cystectomy for
muscle-invasive bladder cancer.
Scand J Urol. 2024;59:39-46.
PubMed
Abstract available
Impact of sarcopenia on outcomes of bladder cancer undergoing radical cystectomy:
A systematic review and meta-analysis.
Scott Med J. 2024 Feb 29:369330241234690. doi: 10.1177/00369330241234690.
PubMed
Abstract available
Simulation of the effects of molecular urine markers in follow-up of patients
with high-risk non-muscle invasive bladder cancer.
Urol Oncol. 2024 Feb 24:S1078-1439(24)00041.
PubMed
Abstract available
Survivin as a potential biomarker in the diagnosis of bladder cancer: A
systematic review and meta-analysis.
Urol Oncol. 2024 Feb 27:S1078-1439(24)00019.
PubMed
Abstract available
Bladder Cancer: Immunotherapy and Pelvic Lymph Node Dissection.
Vaccines (Basel). 2024;12:150.
PubMed
Abstract available
Letter to the editor for the article "Prognostic factors of intravesical
recurrence after radical nephroureterectomy for upper tract urothelial
carcinoma".
World J Urol. 2024;42:101.
PubMed
Improvements in urinary symptoms, health-related quality of life, and
psychosocial distress in the early recovery period after radical cystectomy and
urinary diversion in 842 German bladder cancer patients: data from
uro-oncological rehabilitation.
World J Urol. 2024;42:111.
PubMed
Abstract available
Neoadjuvant combination therapy (immunotherapy and chemotherapy) and
treatment-related biomarkers in upper tract urothelial carcinoma.
World J Urol. 2024;42:110.
PubMed
Thank you for your interest in scientific medicine.